HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program
The funds from the DOD contract will enable Theradaptive to continue its work to meet regulatory requirements and scale up Good Manufacturing Practices-compliant manufacturing of the OsteoAdapt product in preparation for clinical studies.
Macrolux Completes Nearly CNY100 million Series A Round: Funding Led by Legend Capital
Legend Capital has long been paying attention to the investment in the field of medical devices and diagnostics with a focus on three major themes: first, major diseases, especially the unmet clinical needs of chronic diseases; second, the first and uniqueness in technology, which enables a company to become or have the potential to become a leading player in subdivided industries; the third is the "device +" investment opportunities brought by the integration of medical devices and interdisciplinary technologies such as AI, IoT and Big Data.
Previa Medical Raises €2.1 Mil for AI Solution to Prevent Sepsis
Sepsis is one of the leading causes of hospital deaths worldwide, with a 30-day mortality rate of 20 to 30%. SEPSI-SCORE therefore provides a much-needed solution to a major global public health issue.
JelikaLite Announces Positive Results From a New Feasibility Study, Successful Raise of $760,000 and Acceptance into Mount Sinai Elementa Labs Program
JelikaLite notes the pilot study data suggests that JelikaLite’s Cognilum medical device reduces symptoms of autism in young children and improves the quality of life of their families.
Dymicron Launches Regulation A+ Equity Crowdfunding Investment Offering
Dymicron has partnered with DealMaker for its self-hosted $15.8 million raise. Regulation A+ raise. Regulation A+ is a relatively new exemption which allows private companies to sell their shares to unaccredited investors.
Miach Orthopaedics Secures $40 Million Financing
Miach Orthopaedics advises funds will enable ongoing operations and expand the U.S. commercial rollout of the BEAR Implant.
Ferronova Secures A$11 Million to Advance Nanotech Image-guided Cancer Therapy
Ferronova CEO Stewart Bartlett said raising capital in a challenging environment and winning a CRC-P grant was a credit to the strength of Ferronova's technology.
Visura Announces Closing of Series B Financing
Funding will support the company's rapid, full commercialization of its TEECAD® System. "These significant investments underscore the tremendous confidence in our state-of-the-art solution, experienced team, and the growth trajectory we are on to fully commercialize our TEECAD System," says Christine Horton, president and CEO of Visura.
Cardiac Dimensions Raises $35M in Series D Round
Cardiac Dimensions reports financing was co-led by existing investor Horizon 3 Healthcare and an undisclosed strategic investor, with all other existing investors participating, including Arboretum Ventures, Hostplus, EQT Life Sciences (formerly LSP), Lumira Ventures, and M. H. Carnegie & Co.
